Internationally renowned cardiologist Professor John McMurray, widely recognised as one of the world’s leading authorities on the epidemiology and clinical management of heart disease, has joined the Mary MacKillop Institute for Health Research.
Throughout his distinguished career, Professor McMurray has instigated and led a seminal body of cardiovascular clinical and public health research that has led to major advances in the way heart disease (most notably heart failure) is managed and significantly improved the outlook and life expectancy of millions of people around the world.
This includes being Principal Investigator of one of the largest and most influential studies of its kind – the recently reported PARADIGM-HF Trial. In 2013, Professor McMurray was identified as one of the 400 most influential biomedical researchers in the world, and in 2014 and 2016 was included in the Thomson Reuters Highly Cited Researchers list as one of The World's Most Influential Scientific Minds.
Professor McMurray has published around 700 original papers, reviews, and book chapters in leading medical and cardiology textbooks. He has held many prestigious positions, including being Past-President of the Heart Failure Society of the European Society of Cardiology and won many prestigious international awards for his research. Professor McMurray’s appointment consolidates a long and fruitful history of collaboration with the Director of the MacKillop - Professor Simon Stewart.
Professor McMurray's primary research interests are in heart failure, coronary heart disease, atrial fibrillation and the cardiovascular consequences of diabetes and chronic kidney disease, with a focus on clinical trials and epidemiology.
Professor McMurray has been a member and chair of many guideline committees. He was the lead author of the World Health Organization and first Scottish Intercollegiate Guidelines Network Guidelines on the Management of HF. In addition he was a member of the 2008 ESC HF Guidelines Task Force, and Chair of the 2012 Task Force and member of the 2013 American College of Cardiology/American Heart Association HF Guidelines Committee and the 2014 National Institute for Health and Care Excellence (NICE) Acute HF Guideline Committee.
He is a member of the editorial board of the New England Journal of Medicine and sits on the editorial board of several leading cardiovascular journals, including the European Heart Journal (where he is an Associate Editor) and Circulation.